Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2014*

The Package Includes
* A progress analysis on current and emerging drugs
* Information on most companies active in the development of PKIs in oncology
* Information on key industry related PKI drug projects in oncology
* Data from most important clinical trials
* Information on early developmental stage projects
* Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:
* Tracking cutting edge companies, therapies and new technologies
* Rapid identification of partners & competitors
* Laying down a comprehensive framework for further analysis of the field
* Producing presentations surrounding the development of PKI drugs in oncology
* Identifying emerging PKI cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of PKI drug development in cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Table Of Contents

Analytical Tool - Protein Kinase Inhibitors in Oncology

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Pilocytic Astrocytoma Global Clinical Trials Review, H1, 2015

Pilocytic Astrocytoma Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Pilocytic Astrocytoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Pilocytic Astrocytoma Global Clinical Trials Review, H1, 2015" provides data on the Pilocytic ...

Thymus Carcinoma Global Clinical Trials Review, H1, 2015

Thymus Carcinoma Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Thymus Carcinoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Thymus Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Thymus Carcinoma clinical ...

Intestinal Cancer Global Clinical Trials Review, H1, 2015

Intestinal Cancer Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Intestinal Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H1, 2015" provides data on the Intestinal Cance ...


Download Unlimited Documents from Trusted Public Sources

Chemotherapy Market in the US

  • April 2015
    2 pages
  • Chemotherapy  

    Oncology  

    Cancer Therapy  

  • United States  

View report >

Nursing Home Industry in the US and Canada

  • April 2015
    17 pages
  • Nursing Home  

  • United States  

    Canada  

View report >

Therapy Markets in the US - Forecast

  • April 2015
    5 pages
  • Therapy  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.